Investigating the antimicrobial and antibiofilm properties of marine halophilic Bacillus species against ESKAPE pathogens

Monica M. Murphy,Eamonn P. Culligan,Craig P. Murphy

DOI: https://doi.org/10.1111/1758-2229.70027

IF: 4.006

2024-10-26

Environmental Microbiology Reports

Abstract:Biofilms are responsible for approximately 80% of chronic infections, providing bacteria with an innate tolerance to antibiotics. However, once biofilm cells disperse, they quickly regain susceptibility. This study investigated the potential of bacterial isolates from aquatic environments to combat biofilm‐forming pathogens. These isolates not only inhibited biofilm formation but also demonstrated the ability to disrupt preformed biofilms of various clinically relevant pathogens, including MRSA, clinical Staphylococcus aureus, Acinetobacter baumannii and Escherichia coli strains. Antimicrobial resistance (AMR), known as the "silent pandemic," is exacerbated by pathogenic bacteria's ability to form biofilms. Marine compounds hold promise for novel antibacterial drug discovery. Two isolates from preliminary saltwater environment screening demonstrated antimicrobial activity and were subsequently identified as Bacillus subtilis MTUA2 and Bacillus velezensis MTUC2. Minimum inhibitory concentrations (MICs), minimum biofilm inhibition concentrations (MBICs) and minimum biofilm eradication concentrations (MBECs) required to prevent and/or disrupt bacterial growth and biofilm formation were established for MRSA, Staphylococcus aureus, Acinetobacter baumannii and Escherichia coli. The metabolic activity within biofilms was determined by the 2,3,5‐triphenyltetrazolium chloride assay. Both Bacillus species exhibited unique antimicrobial effects, reducing MRSA and S. aureus planktonic cell growth by 50% and sessile cell growth for S. aureus and E. coli by 50% and 90%, respectively. No effect was observed against A. baumannii. Significant MBIC and MBEC values were achieved, with 99% inhibition and 90% reduction in MRSA and S. aureus biofilms. Additionally, 90% and 50% inhibition was observed in E. coli and A. baumannii biofilms, respectively, with a 50% reduction in E. coli biofilm. These findings suggest that the mode of action employed by B. subtilis MTUA2 and B. velezensis MTUC2 metabolites should be further characterized and could be beneficial if used independently or in combination with other treatments.

microbiology,environmental sciences